Upgrade to SI Premium - Free Trial

Jefferies Assumes Allogene (ALLO) at Buy

April 10, 2026 1:56 AM
Jefferies analyst Roger Song assumes coverage on Allogene (NASDAQ: ALLO) with a Buy rating and a price target of $6.00.The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage